Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: The PREDICT study

European Heart Journal

Volumn 29, Issue 18, 2008, Pages 2244-2251

  Elkeles, Robert S ^a,b   Godsland, Ian F ^a   Feher, Michael D ^c   Rubens, Michael B ^d   Roughton, Michael ^e   Nugara, Fiona ^d   Humphries, Steve E ^f   Richmond, William ^b   Flather, Marcus D ^d,e  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Coronary calcification; Coronary events; Stroke; Type 2 diabetes

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN; C REACTIVE PROTEIN; CREATININE; FIBRIC ACID DERIVATIVE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPOPROTEIN;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY RISK; CREATININE URINE LEVEL; ELECTRON BEAM TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STROKE;

AGED; C-REACTIVE PROTEIN; CALCINOSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52449104073     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn279     Document Type: Article

References (23)

1. Pyörälä K, Laakso M. Macrovascular disease in diabetes. In: Mann J, Pyörälä K, Teuscher A, (ed). Diabetes in Epidemiological Perspective. Churchill Livingstone: 1983. p183-247.
2. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393.
3. Anderson KM, Odell PM, Wilson PWF, Kannel W. Cardiovascular disease risk profiles. Am Heart J 1990;121:293-298.
4. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 2001;101:671-679.
5. Ardehali R, Nasir K, Kolandaivelu A, Budoff M, Blumenthal RS. Screening patients for subclinical atherosclerosis with non-contrast cardiac CT. Atherosclerosis 2007;192:235-242.
6. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St Francis Heart Study. J Am Coll Cardiol 2005;46:158-165.
7. Qu W, Le TT, Azen SP, Xiang M, Wong ND, Doherty TM, Detrano RC. Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care 2003;26:905-910.
8. Bax JJ, Inzucchi SE, Bonow RO, Schuijf JD, Freeman MR, Barrett EJ, for the Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients with Diabetes. Cardiac imaging for risk stratification in diabetes. Cardiac imaging for risk stratification in diabetes. Diab Care 2007;30:1295-1304.
9. Elkeles RS, Flather M, Feher MD, Godsland I, Richmond W, Humphries SE, Rubens MB, Underwood SR. Prospective evaluation of diabetic ischaemic heart disease by computed tomography: the PREDICT study. Br J Diabetes Vasc Dis 2002;2:69-72.
10. Wild S, Mckeigue P. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. Br Med J 1997;314:705-710.
11. Agatston AS, Janowitz WR, Hilner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
12. Elkeles RS, Feher MD, Flather MD, Godsland IF, Nugara F, Richmond W, Rubens MB, Wang D, for the PREDICT Study Group. The association of coronary calcium score and conventional cardiovascular risk factors in type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study). Diab Med 2004;21:1129-1134.
13. Godsland IF, Elkeles RS, Feher MD, Nugara F, Rubens MB, Richmond W, Khan M, Donovan J, Anyaoku V, Flather MD. Coronary calcification, homocysteine, Creactive protein and the metabolic syndrome in type 2 diabetes: the PREDICT Study. Diab Med 2006;23:1192-1200.
14. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
16. Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
17. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663-1669.
18. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, Flores FR, Callister TQ, Raggi P, Berman DS. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-1870.
19. Turner RC, Milns H, Neil HW, Stratton IM, Manley SE, Matthews DR, Holman RR, for the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus United Kingdom prospective diabetes study (UKPDS 23). Br Med J 1998;316:823-828.
20. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-1345.
21. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P, Lipkin D, Lahiri A. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 2006;27:713-721.
22. Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RM. Effect of of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis and cancer. Insights from large randomized statin trials. J Am Coll Cardiol 2007;50:409-418.
23. Stanford W, Thompson BH, Burns TL, Heery SDE, Burr MC. Coronary artery calcium quantification at multi-detector row helical CT versus electron beam CT. Radiology 2004;230:397-402.